Dr Kathelijn Fischer
Kathelijn Fischer has been working at the University Medical Center Utrecht, both as a Paediatric Haematologist and a Clinical Epidemiologist.
Dr Fischer finished her medical training in 1988 and her residency in paediatrics in the Netherlands and the Netherlands Antilles in 1994. After her registration in paediatrics, Dr Fischer specialized in paediatric haematology and oncology in the Wilhelmina Children’s Hospital in Utrecht, the Netherlands. Subsequently, Dr Fischer did her PhD research in haemophilia while training as a clinical epidemiologist. She finished writing her thesis on ‘Treatment strategies in severe haemophilia: in search for the optimal treatment’ in 2001.
Dr Fischer is a member of several international working groups: International Prophylaxis Study Group (IPSG; co-chair Economics and pharmacokinetics working group, member PK working group), European Association for Haemophilia and Allied Disorders (EAHAD; secretary of the steering committee), she is a former co-chair of the FVIII/IX SSC subcommittee of the ISTH and participated in the European Interdisciplinary Working Group (IDWG) subgroup that drafted the Principles of Haemophilia Care. Dr Fischer is principal investigator in several international studies on long-term results of haemophilia treatment, and is the epidemiologist for the European Haemophilia Safety Surveillance Study (EUHASS-member of the steering committee) as well as for the European PedNet-Rodin registry on inhibitors, treatment and outcome in paediatric haemophilia.
The specific areas of expertise and interest of Dr. Fischer include the epidemiology of haemophilia (including use of registries), prophylactic treatment, and outcome assessment in haemophilia care.